India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

The global aerosol delivery devices market size was US$ 14.5 billion in 2021. The global aerosol delivery devices market is forecast to grow to US$ 21.1 billion by 2030 by growing at a compound annual ...

Cipla Ltd. today launched its nationwide awareness initiative, #InhaleTheChange, aimed at encouraging better insulin adherence through empowerment, and destigmatization. These efforts reflect Cipla's ...

HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the Group") is pleased to announce the official signing of a tripartite ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

Many of us begin a new year hoping to become better versions of ourselves. Some aim to improve their health, others focus on ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

US gastrointestinal (GI) and rare diseases specialist has announced financial guidance for full year 2026, which pleased ...

We are mindful that opinion is growing about whether this is caused by the eye itself or a new factor called type III ...